Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;24(3):e25671.
doi: 10.1002/jia2.25671.

Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study

Lisa J Frigati  1   2 , Katalin A Wilkinson  3   4 , Stanzi le Roux  5 , Karryn Brown  5 , Sheena Ruzive  3 , Leah Githinji  1 , Wonita Petersen  1 , Sabine Belard  6   7 , Mark F Cotton  2 , Landon Myer  5 , Heather J Zar  1   8
Affiliations

Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study

Lisa J Frigati et al. J Int AIDS Soc. 2021 Mar.

Abstract

Introduction: There are limited data on Tuberculosis (TB) in adolescents with perinatally acquired HIV (APHIV). We examined the incidence and determinants of TB infection and disease in the Cape Town Adolescent Antiretroviral Cohort (CTAAC).

Methods: Youth between nine and fourteen years on antiretroviral therapy (ART) for more than six months in public sector care, and age-matched HIV-negative adolescents, were enrolled between July 2013 through March 2015 and followed six-monthly. Data were censored on 31 October 2018. Symptom screening, chest radiograph, viral load, CD4 count, QuantiFERON (QFT) and sputum for Xpert MTB/RIF, microscopy, culture and sensitivity were performed annually. TB infection was defined by a QFT of >0.35 IU/mL. TB diagnosis was defined as confirmed (culture or Xpert MTB/RIF positive) or unconfirmed (clinical diagnosis and started on TB treatment). Analyses examined the incidence and determinants of TB infection and disease.

Results: Overall 496 HIV+ and 103 HIV-negative participants (median age at enrolment 12 years (interquartile range, IQR 10.6 to 13.3) were followed for a median of 3.1 years (IQR 3.0 to 3.4); 50% (298/599) were male. APHIV initiated ART at median age 4.4 years (IQR 2.1 to 7.6). At enrolment, 376/496 (76%) had HIV viral load <40 copies/mL, median CD4 count was 713 cells/mm3 and 179/559 (32%) were QFT+, with no difference by HIV status (APHIV 154/468, 33%; HIV negative 25/91, 27%; p = 0.31). The cumulative QFT+ prevalence was similar (APHIV 225/492, 46%; 95%CI 41% to 50%; HIV negative 44/98, 45%; 95% CI 35% to 55%; p = 0.88). APHIV had a higher incidence of all TB disease than HIV-negative adolescents (2.2/100PY, 95% CI 1.6 to 3.1 vs. 0.3/100PY, 95% CI 0.04 to 2.2; IRR 7.36, 95% CI 1.01 to 53.55). The rate of bacteriologically confirmed TB in APHIV was 1.3/100 PY compared to 0.3/100PY for HIV-negative adolescents, suggesting a fourfold increased risk of developing TB disease in APHIV despite access to ART. In addition, a positive QFT at enrolment was not predictive of TB in this population.

Conclusions: High incidence rates of TB disease occur in APHIV despite similar QFT conversion rates to HIV-negative adolescents. Strategies to prevent TB in this vulnerable group must be strengthened.

Keywords: HIV; adolescents; coinfection; incidence; perinatal; tuberculosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram.
Figure 2
Figure 2
Kaplan‐Meier estimates for QFT conversion among APHIV and HIV‐negative youth over the first 36 months of follow‐up, stratified by time‐varying HIV viral load: (a) overall and (b) with restricted Y‐axis.
Figure 3
Figure 3
Relative hazard of (a) QFT conversion and (b) incident tuberculosis disease comparing APHIV to HIV‐negative youth in strata of HIV viral control during follow‐up.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Marais B, Gie R, Schaaf H, Hesseling AC, Obihara CC, Starke JJ, et al. The natural history of childhood intra‐thoracic tuberculosis: a critical review of literature from the pre‐chemotherapy era [State of the Art]. Int J Tuberc Lung Dis. 2004;8(4):392–402. - PubMed
    1. Dodd PJ, Looker C, Plumb ID, Bond V, Schaap A, Shanaube K, et al. Age‐ and sex‐specific social contact patterns and incidence of mycobacterium tuberculosis infection. Am J Epidemiol. 2016;183(2):156–66. - PMC - PubMed
    1. Snow KJ, Sismanidis C, Denholm J, Sawyer SM, Graham SM. The incidence of tuberculosis among adolescents and young adults: a global estimate. Eur Respir J. 2018;51:1702352. - PubMed
    1. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99(2):131–8. - PubMed
    1. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Nelson LJ, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre‐chemotherapy era [State of the Art]. Int J Tuberc Lung Dis. 2004;8(3):278–85. - PubMed

Publication types